EM
Escalon Medical Corp Stock: price and insider trades · United States
US·Mcap US$1.4M
Escalon Medical Corp: what insiders have been doing
Insider filings for Escalon Medical Corp are scarce in the SEC (Form 4) feed, the latest one published on 21 December 2012. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 4,943 of 26,911 companies
68.0
score / 100
Value54
Quality82
FCF yld-29%
Earn yld·
EV/EBITDA0.8x
ROE102%
Gross mgn44%
Net mgn16%
Debt/EBITDA0.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended June 2026 · cache
US$0.19
Analyst consensus
Income statement
RevenueUS$12.7M
Gross profitUS$5.6M44% margin
EBITDAUS$2.9M23% margin
Net incomeUS$2M31.5% margin
Valuation
PER (trailing)0.7x
P/Book0.3x
Beta0.57
Balance sheet & cash
Market capUS$1.4M
Total debtUS$974.7k
Free Cash Flow-US$407k
Debt / Equity16%
Profitability & ownership
ROE102.3%
ROA0.4%
% insiders1.9%
% institutions7.9%
Last declaration on 21 December 2012
Declarations1 total
- 500 shares@ US$1.08Common StockSEC:0001311924-12-000001:0
1 of 1 declaration
About Escalon Medical Corp
Escalon Medical Corp is a company focused on the development and commercialization of medical devices. It operates in the OTCM market.